the tumour determinant being from liver or pancreas cancer cell

Industry

CPC
A61K47/486

This industry / category may be too specific. Please go to a parent level for more data

Parent Industries

AHUMAN NECESSITIES A61Medical science A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES A61K47/00Medicinal preparations characterised by the non-active ingredients used

Current Industry

A61K47/486the tumour determinant being from liver or pancreas cancer cell

Industries

Patents Grantslast 30 patents

Information Patent Grant
Antibody-drug conjugates and the use of same in therapy
- Patent number 10,307,488
- Issue date Jun 4, 2019
- Universite Francois Rabelais
- Nicolas Joubert
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Combination therapy for inducing immune response to disease
- Patent number 10,245,321
- Issue date Apr 2, 2019
- IBC Pharmaceuticals, Inc.
- Chien-Hsing Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CDH6 antibody drug conjugates
- Patent number 10,238,748
- Issue date Mar 26, 2019
- Novartis AG
- Carl Uli Bialucha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Site-specific antibody-drug conjugation through glycoengineering
- Patent number 10,214,589
- Issue date Feb 26, 2019
- Genzyme Corporation
- Clark Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synergistic effects between auristatin-based antibody drug conjugat...
- Patent number 10,201,615
- Issue date Feb 12, 2019
- Seattle Genetics, Inc.
- Timothy S. Lewis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-HER2 antibody-drug conjugate
- Patent number 10,155,821
- Issue date Dec 18, 2018
- Daiichi Sankyo Company, Limited
- Hiroyuki Naito
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preventing tumor development and metastasis
- Patent number 10,137,143
- Issue date Nov 27, 2018
- The Administrators of the Tulane Educational Fund
- Eckhard Alt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibody-drug conjugates and immunotoxins
- Patent number 10,137,202
- Issue date Nov 27, 2018
- Oncomatryx Biopharma, S.L.
- Roland Kontermann
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-DLL3 antibody drug conjugates for treating cancer
- Patent number 10,137,204
- Issue date Nov 27, 2018
- ABBVIE STEMCENTRX LLC
- Robert A. Stull
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-drug conjugates and uses thereof
- Patent number 10,130,718
- Issue date Nov 20, 2018
- Immunomedics, Inc.
- David M. Goldenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination therapy with T-cell redirecting bispecific antibodies a...
- Patent number 10,131,712
- Issue date Nov 20, 2018
- IBC Pharmaceuticals, Inc.
- Edmund A. Rossi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-HER2 antibody-drug conjugate
- Patent number 10,118,972
- Issue date Nov 6, 2018
- Daiichi Sankyo Company, Limited
- Hiroyuki Naito
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conj...
- Patent number 10,098,963
- Issue date Oct 16, 2018
- Seattle Genetics, Inc.
- Eric Sievers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Duocarmycin ADCs for use in treatment of endometrial cancer
- Patent number 10,092,659
- Issue date Oct 9, 2018
- Synthon Biopharmaceuticals B.V.
- Alessandro Davide Santin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibody-drug conjugate having improved stability and use thereof
- Patent number 10,071,170
- Issue date Sep 11, 2018
- ABLBIO
- Young Min Kim
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Glycoengineered antibody drug conjugates
- Patent number 10,064,952
- Issue date Sep 4, 2018
- Genzyme Corporation
- Luis Z. Avila
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Chimeric small molecules for the recruitment of antibodies to cance...
- Patent number 10,066,026
- Issue date Sep 4, 2018
- Yale University
- David Spiegel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for treating cancer by administering humanized pan-HER anti...
- Patent number 10,058,610
- Issue date Aug 28, 2018
- SYMPHOGEN A/S
- Johan Lantto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy with anti-HLA-DR antibodies and kinase inhibito...
- Patent number 10,058,621
- Issue date Aug 28, 2018
- Immunomedics, Inc.
- David M. Goldenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-mesothelin antibodies and immunoconjugates
- Patent number 10,022,452
- Issue date Jul 17, 2018
- Genentech, Inc.
- Mark Dennis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon lambda-antibody complexes
- Patent number 10,022,427
- Issue date Jul 17, 2018
- IBC Pharmaceuticals, Inc.
- Chien-Hsing Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Recombinant monoclonal antibodies and corresponding antigens for co...
- Patent number 10,023,650
- Issue date Jul 17, 2018
- Precision Biologics, Inc.
- J. Andrew Bristol
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CS1 antibodies and antibody drug conjugates
- Patent number 10,011,657
- Issue date Jul 3, 2018
- AbbVie Biotherapeutics Inc.
- Kurt C. Gish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Molecular constructs with targeting and effector moieties
- Patent number 10,010,626
- Issue date Jul 3, 2018
- Tse-Wen Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolobenzodiazepine-antibody conjugates
- Patent number 10,010,624
- Issue date Jul 3, 2018
- MedImmune Limited
- Philip Wilson Howard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compositions and methods for the diagnosis and treatment of tumor
- Patent number 9,994,643
- Issue date Jun 12, 2018
- Genentech, Inc.
- Mark Dennis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds comprising self-immolative group
- Patent number 9,993,568
- Issue date Jun 12, 2018
- Legochem Biosciences, Inc.
- Yong Zu Kim
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin conjugate using an immunoglobulin fragment
- Patent number 9,981,017
- Issue date May 29, 2018
- Hanmi Science Co., Ltd
- Dae Hae Song
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-Axl antibodies
- Patent number 9,975,954
- Issue date May 22, 2018
- BerGenBio ASA
- David Robert Micklem
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Humanized anti-CD22 antibody
- Patent number 9,944,703
- Issue date Apr 17, 2018
- Immunomedics, Inc.
- Chien-Hsing Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF
- Publication number 20180371435
- Publication date Dec 27, 2018
- ALX Oncology Inc.
- Laura DEMING
- C07 - ORGANIC CHEMISTRY
Information Patent Application
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...
- Publication number 20180369317
- Publication date Dec 27, 2018
- Seattle Genetics, Inc.
- Eric Sievers
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
- Publication number 20180222979
- Publication date Aug 9, 2018
- AbbVie Biotherapeutics Inc.
- Kurt C. Gish
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HODGKIN LYMPHOMA THERAPY
- Publication number 20180098969
- Publication date Apr 12, 2018
- PURDUE PHARMACEUTICAL PRODUCTS L.P.
- Thomas Mehrling
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES
- Publication number 20170290920
- Publication date Oct 12, 2017
- MEDIMMUNE LIMITED
- Paul Polakis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
JAM-C ANTIBODIES AND METHODS FOR TREATMENT OF CANCER
- Publication number 20170291944
- Publication date Oct 12, 2017
- Research Development Foundation
- Beat IMHOF
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE
- Publication number 20170281767
- Publication date Oct 5, 2017
- IBC Pharmaceuticals, Inc.
- Chien-Hsing Chang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATES INCLUDING AN ANTIBODY MOIETY, A POLYPEPTIDE THAT TRAVERS...
- Publication number 20170281787
- Publication date Oct 5, 2017
- ANGIOCHEM INC.
- Jean-Paul Castaigne
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
c-Met Antibody Drug Conjugate
- Publication number 20170281796
- Publication date Oct 5, 2017
- Sorrento Therapeutics, Inc.
- Tong Zhu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-MESOTHELIN ANTIBODIES AND IMMUNOCONJUGATES
- Publication number 20170281792
- Publication date Oct 5, 2017
- Genentech, Inc.
- Mark DENNIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...
- Publication number 20170281794
- Publication date Oct 5, 2017
- Seattle Genetics, Inc.
- Eric Sievers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DLL3 MODULATORS AND METHODS OF USE
- Publication number 20170274094
- Publication date Sep 28, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
ANTIBODIES AND MOLECULES DERIVED THEREFROM THAT BIND TO STEAP-1 PRO...
- Publication number 20170275377
- Publication date Sep 28, 2017
- Agensys, Inc.
- Aya JAKOBOVITS
- G01 - MEASURING TESTING
Information Patent Application
DRUG DELIVERY OF TEMOZOLOMIDE FOR SYSTEMIC BASED TREATMENT OF CANCER
- Publication number 20170274085
- Publication date Sep 28, 2017
- Cedars-Sinai Medical Center
- Rameshwar Patil
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH T-CELL REDIRECTING BISPECIFIC ANTIBODIES A...
- Publication number 20170275375
- Publication date Sep 28, 2017
- IBC Pharmaceuticals, Inc.
- Edmund A. Rossi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRO-DRUG FORM (P2PDOX) OF THE HIGHLY POTENT 2-PYRROLINODOXORUBICIN...
- Publication number 20170266310
- Publication date Sep 21, 2017
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS OF MAKING DLL3 ANTIBODY DRUG CONJUGATES
- Publication number 20170266314
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
SUBCUTANEOUS ADMINISTRATION OF ANTI-CD74 ANTIBODY FOR SYSTEMIC LUPU...
- Publication number 20170266281
- Publication date Sep 21, 2017
- Immunomedics, Inc.
- David M. Goldenberg
- B82 - NANO-TECHNOLOGY
Information Patent Application
ANTI-DLL3 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER
- Publication number 20170266315
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING
- Publication number 20170267774
- Publication date Sep 21, 2017
- Genzyme Corporation
- Clark PAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of Treating Ovarian and Renal Cancer Using Antibodies Agains...
- Publication number 20170267750
- Publication date Sep 21, 2017
- CELLDEX THERAPEUTICS, INC.
- Kam Fai Tse
- B82 - NANO-TECHNOLOGY
Information Patent Application
ANTI-DLL3 ANTIBODY DRUG CONJUGATES
- Publication number 20170266312
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES
- Publication number 20170266313
- Publication date Sep 21, 2017
- AbbVie Stemcentrx LLC
- ROBERT A. STULL
- G01 - MEASURING TESTING
Information Patent Application
Immunoconjugates with an Intracellularly-Cleavable Linkage
- Publication number 20170266316
- Publication date Sep 21, 2017
- Immunomedics, Inc.
- Serengulam V. Govindan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MACROCYCLIC BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, PREPARATION...
- Publication number 20170260205
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Yong ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tunable pH-Sensitive Linker for Controlled Drug Release
- Publication number 20170258936
- Publication date Sep 14, 2017
- Washington State University
- Clifford E. Berkman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE
- Publication number 20170260232
- Publication date Sep 14, 2017
- Bristol-Myers Squibb Company
- Qiang CONG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGETING PROSTATE AND OT...
- Publication number 20170240643
- Publication date Aug 24, 2017
- The Regents of the University of California
- BIN LIU
- G01 - MEASURING TESTING
Information Patent Application
GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THE...
- Publication number 20170240646
- Publication date Aug 24, 2017
- GANYMED PHARMACEUTICALS AG
- Ozlem Tureci
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES
- Publication number 20170240645
- Publication date Aug 24, 2017
- Genentech, Inc.
- Youjun Chen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

the tumour determinant being from liver or pancreas cancer cell

Industry

Parent Industries

Current Industry

Patents Grantslast 30 patents

Antibody-drug conjugates and the use of same in therapy

Combination therapy for inducing immune response to disease

Anti-CDH6 antibody drug conjugates

Site-specific antibody-drug conjugation through glycoengineering

Synergistic effects between auristatin-based antibody drug conjugat...

Anti-HER2 antibody-drug conjugate

Preventing tumor development and metastasis

Antibody-drug conjugates and immunotoxins

Anti-DLL3 antibody drug conjugates for treating cancer

Antibody-drug conjugates and uses thereof

Combination therapy with T-cell redirecting bispecific antibodies a...

Anti-HER2 antibody-drug conjugate

Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conj...

Duocarmycin ADCs for use in treatment of endometrial cancer

Antibody-drug conjugate having improved stability and use thereof

Glycoengineered antibody drug conjugates

Chimeric small molecules for the recruitment of antibodies to cance...

Methods for treating cancer by administering humanized pan-HER anti...

Combination therapy with anti-HLA-DR antibodies and kinase inhibito...

Anti-mesothelin antibodies and immunoconjugates

Interferon lambda-antibody complexes

Recombinant monoclonal antibodies and corresponding antigens for co...

Anti-CS1 antibodies and antibody drug conjugates

Molecular constructs with targeting and effector moieties

Pyrrolobenzodiazepine-antibody conjugates

Compositions and methods for the diagnosis and treatment of tumor

Compounds comprising self-immolative group

Insulin conjugate using an immunoglobulin fragment

Anti-Axl antibodies

Humanized anti-CD22 antibody

Patents Applicationslast 30 patents

SIRP-ALPHA VARIANT CONSTRUCTS AND USES THEREOF

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...

ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES

HODGKIN LYMPHOMA THERAPY

ANTI-CD22 ANTIBODIES AND IMMUNOCONJUGATES

JAM-C ANTIBODIES AND METHODS FOR TREATMENT OF CANCER

COMBINATION THERAPY FOR INDUCING IMMUNE RESPONSE TO DISEASE

CONJUGATES INCLUDING AN ANTIBODY MOIETY, A POLYPEPTIDE THAT TRAVERS...

c-Met Antibody Drug Conjugate

ANTI-MESOTHELIN ANTIBODIES AND IMMUNOCONJUGATES

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJ...

DLL3 MODULATORS AND METHODS OF USE

ANTIBODIES AND MOLECULES DERIVED THEREFROM THAT BIND TO STEAP-1 PRO...

DRUG DELIVERY OF TEMOZOLOMIDE FOR SYSTEMIC BASED TREATMENT OF CANCER

COMBINATION THERAPY WITH T-CELL REDIRECTING BISPECIFIC ANTIBODIES A...

PRO-DRUG FORM (P2PDOX) OF THE HIGHLY POTENT 2-PYRROLINODOXORUBICIN...

METHODS OF MAKING DLL3 ANTIBODY DRUG CONJUGATES

SUBCUTANEOUS ADMINISTRATION OF ANTI-CD74 ANTIBODY FOR SYSTEMIC LUPU...

ANTI-DLL3 ANTIBODY DRUG CONJUGATES FOR TREATING CANCER

SITE-SPECIFIC ANTIBODY-DRUG CONJUGATION THROUGH GLYCOENGINEERING

Method of Treating Ovarian and Renal Cancer Using Antibodies Agains...

ANTI-DLL3 ANTIBODY DRUG CONJUGATES

METHODS OF DELIVERING DLL3 ANTIBODY DRUG CONJUGATES

Immunoconjugates with an Intracellularly-Cleavable Linkage

MACROCYCLIC BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, PREPARATION...

Tunable pH-Sensitive Linker for Controlled Drug Release

TUBULYSIN COMPOUNDS, METHODS OF MAKING AND USE

INTERNALIZING HUMAN MONOCLONAL ANTIBODIES TARGETING PROSTATE AND OT...

GENETIC PRODUCTS DIFFERENTIALLY EXPRESSED IN TUMORS AND THE USE THE...

ANTI-PMEL17 ANTIBODIES AND IMMUNOCONJUGATES